Cusabio Technology
- Company typePrivate
- Founded2007
- HeadquartersHouston, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Cusabio Technology firmographics
Firmographics- Name
- Cusabio Technology
- Legal name
- CUSABIO TECHNOLOGY LLC
- Website
- https://cusabio.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Cusabio Technology industry classification
Industry- Product category
- Life Science Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
- akta.pro secondary industry
- Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)
Keywords
Where Cusabio Technology is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Cusabio Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Life Science Reagent Products: Sale of research reagents including ELISA kits (3000+ targets), recombinant proteins (15000+), antibodies (67000+), transmembrane proteins (470+), native proteins, peptides, molecular biology products, and small molecules. Products sold directly through e-commerce with 100% risk-free performance guarantee.
- CRO Services: Contract research organization services including protein expression services (E.coli, Yeast, Insect, Mammalian systems), therapeutic antibody discovery, custom antibody production, stable cell line development, peptide synthesis, SPR detection, gene synthesis, and oligo synthesis services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Plasmid DNA Purification Maxiprep Kit - US$140 for 5T*5 |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Cusabio Technology product offering
Product offeringCore offering
CUSABIO Technology manufactures and sells life science research reagents including ELISA kits (3,000+ targets), recombinant proteins (15,000+), and antibodies (67,000+), produced using five proprietary expression systems. The company also operates a CRO services arm offering custom protein expression, therapeutic antibody discovery, phage display screening, stable cell line development, and peptide/gene/oligo synthesis for pharmaceutical, biotechnology, and academic customers globally.
Product overview
CUSABIO is a life science research products company offering a comprehensive portfolio of biological reagents and CRO services. The core offerings include ELISA Kits (3000+ targets), Antibodies (67000+ total including Polyclonal, Monoclonal, and Recombinant), and Recombinant Proteins (15000+) expressed in five systems (E.coli, Yeast, Insect Baculovirus, Mammalian Cell, Cell-free). The company provides specialized products including Transmembrane Proteins (470+) using VLP, Detergent Micelle, and Nanodisc platforms, Exosome Isolation Kits, Plasmid DNA Purification Kits, and HCP Detection ELISA Kits for biopharmaceutical quality control. Supporting services include Therapeutic Antibody Discovery, Protein Expression Services, Phage Display, Stable Cell Line Development, and integrated solutions for ADC Development, CAR-T Therapy, and mRNA Vaccine Research. The product portfolio spans research reagents, custom services, and specialized solutions for drug discovery and development.
Differentiator
Problem solved
Functional benefit
Products and services
- ELISA Kits Enzyme-linked immunosorbent assay kits for detection of protein targets in biological samples including serum, plasma, cell culture supernatant, and tissue lysates; over 3,000+ targets available covering multiple species, used by life science researchers for quantitative protein analysis.
- Recombinant Proteins Laboratory-produced proteins expressed in E. coli, Yeast, Insect Baculovirus, Mammalian cells, or cell-free systems; 15,000+ catalog products with validated bio-activity for drug discovery and basic research applications.
- Antibodies Comprehensive antibody portfolio of 67,000+ products including polyclonal (65,000+), monoclonal (1,000+), recombinant (1,100+), secondary, tag/control, and custom antibodies, validated for ELISA, WB, IHC, IF, IP, FC, and ChIP applications.
- Active Proteins
- Native Proteins
- Transmembrane Proteins
- Exosome Isolation Kits
- Plasmid DNA Purification Maxiprep Kit
- HCP Detection ELISA Kits
- Food Safety & Drug Residues ELISA Kits
- Protein Expression Services
- Therapeutic Antibody Discovery Service
- Custom Antibody Production Services
- Stable Cell Line Development Service
- Phage Display Service
- SPR Detection Service
- Peptide Synthesis Service
- Gene Synthesis Service
- Oligo Synthesis Service
- mRNA Vaccine Research Solutions
- ADC Development Solutions
- CAR-T Therapy Development Solutions
Quantifiable outcome
- 31,000+ published citations in research papers including Nature, Science, Cell, Immunity, Nature Medicine
- +3 more outcomes
Companies that use Cusabio Technology
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Cusabio Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Cusabio Technology partnerships and signals
Strategic signalScale indicators14 records
Recent moves6 records
Expansion highlights6 records
Cusabio Technology competitors and assessment
Company assessmentDirect peers
- Abcam: Abcam (acquired by Danaher) is the dominant global antibody and life science reagent supplier. Directly comparable catalog breadth (antibodies, ELISA kits, proteins), overlapping customer base of academic and pharma researchers, and highly similar product positioning make it the closest direct peer to CUSABIO.
- Sino Biological: China-anchored recombinant protein and antibody supplier with strong catalog and CRO services. Highly comparable product mix (recombinant proteins, antibodies, ELISA kits) and similarly positioned for researchers and biotechs globally.
- GenScript Biotech: Global life science tools and CRO provider offering protein expression services, antibody discovery (phage display), peptide synthesis, gene synthesis, and oligo synthesis. Closely matches CUSABIO's combined catalog-plus-CRO model.
- Cell Signaling Technology (CST): US-based antibody specialist focused on signaling pathway research with rigorously validated antibodies. Direct competitor in the antibody catalog space, especially for academic researchers in cell biology and signal transduction.
- Proteintech: Antibody and protein manufacturer best known for its catalog of polyclonal antibodies. Direct competitor in catalog antibodies, particularly in academic research channels where catalog citation competitiveness is central.
- ABclonal Technology: China-anchored antibody manufacturer with global distribution and a comparable catalog of polyclonal and monoclonal antibodies. Similar origin and product mix make it a directly comparable catalog peer.
Broad incumbents
- Bio-Techne: Diversified life science tools company offering proteins (R&D Systems), antibodies, and ELISA kits across multiple brands. Substantial scale and global reach make it a broad incumbent competing across most of CUSABIO's catalog.
- Thermo Fisher Scientific (Life Sciences): Largest life sciences tools supplier with deep catalog, including antibodies, proteins, ELISA kits, and CRO services. Broad incumbent competing across virtually all of CUSABIO's product categories.
- Bio-Rad Laboratories: Established life science instruments and reagents supplier offering antibodies, ELISA kits, and protein detection tools. Overlaps with CUSABIO across reagent categories within a broader instruments-led portfolio.
Emerging players
- Absolute Antibody: Recombinant antibody expression and engineering specialist offering custom antibody production services. Closely overlaps CUSABIO's custom/recombinant antibody CRO services and competitive in the recombinant antibody catalog.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Cusabio Technology social profiles
Digital presenceCusabio Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cusabio Technology leadership team
Management profileNumber of profiles
Profiles1 record
Cusabio Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cusabio Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cusabio Technology
What does Cusabio Technology do?
CUSABIO Technology manufactures and sells life science research reagents including ELISA kits (3,000+ targets), recombinant proteins (15,000+), and antibodies (67,000+), produced using five proprietary expression systems. The company also operates a CRO services arm offering custom protein expression, therapeutic antibody discovery, phage display screening, stable cell line development, and peptide/gene/oligo synthesis for pharmaceutical, biotechnology, and academic customers globally.
Is Cusabio Technology a public or private company?
Cusabio Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cusabio Technology founded?
Cusabio Technology was founded in 2007. It employs 501 to 1,000 people.
Where is Cusabio Technology based?
Cusabio Technology is headquartered in Houston, United States, in the North America region.
How does Cusabio Technology make money?
Two revenue lines are on record. Life Science Reagent Products are the primary driver. The others are CRO Services.
Who are Cusabio Technology's main competitors?
Direct peers on record are Abcam, Sino Biological, GenScript Biotech, Cell Signaling Technology (CST), Proteintech and ABclonal Technology. Broad incumbents are Bio-Techne, Thermo Fisher Scientific (Life Sciences) and Bio-Rad Laboratories. Absolute Antibody is listed as an emerging player.
Does Cusabio Technology have an API?
No public API is recorded for Cusabio Technology.
What industry is Cusabio Technology in?
Cusabio Technology's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 325413 and its SIC code is 2835.